Screening of five specific cell cycle inhibitors using a T cell lymphoma cell line synchrony/release assay.
To obtain different cell populations at specific cell cycle stages, we used a cell culture synchronization protocol. Effects of five different cell cycle inhibitors acting throughout the cell cycle were examined by DNA flow cytometric analysis of a synchrony/release lymphoma cell line (CEM). The screening synchronized protocol showed that staurosporine, mimosine and aphidicolin are reversible G1 phase inhibitors that act at different times. Staurosporine acted in early G1, exhibited the strongest cytotoxic effect, and induced apoptosis. Mimosine and aphidicolin acted in late G1 and at the G1/S boundary, respectively. Hydroxyurea arrested CEM cells in early S phase, but later than the aphidicolin arrest point. Nocodazole synchronized CEM cells in M phase. All the inhibitors examined in this study can be used to synchronize cells at different phases of the cell cycle and were reversible with little toxicity except for staurosporine which is highly toxic. Because the regulatory mechanism of the cell cycle is disrupted by their effects on protein synthesis, however, these drugs must be used with caution.
Yerly-Motta
V
V
Cellular Immunology Laboratory, ETS Franche-Comté, Besançon, France.
Pavy
J J
JJ
Hervé
P
P
D016590:Aphidicolin / Q000494:pharmacology*; D002453:Cell Cycle; D006801:Humans; D006918:Hydroxyurea / Q000494:pharmacology*; D016399:Lymphoma, T-Cell; D008898:Mimosine / Q000494:pharmacology*; D015739:Nocodazole / Q000494:pharmacology*; D019311:Staurosporine / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
D016590:Aphidicolin; D008898:Mimosine; D019311:Staurosporine; D015739:Nocodazole; D006918:Hydroxyurea